Sectorial Brochure Pharmaceutical Sector of Armenia/ BA | Page 8

1
Having a common pharmaceutical market with EAEU countries
with 0% customs duties means registered pharmaceutical
products can freely circulate in EAEU countries without any
additional procedures. The GMP standard is being implemented
among the member countries
Within investment programs, eight pharmaceutical companies are exempt from
customs duties when importing certain industry products
AN INNOVATIVE ECOSYSTEM FOR
THE DEVELOPMENT OF MEDICINE,
CHEMISTRY AND GENETICS
£ Analytical Laboratory SCDMTE won first place in professional testing studies
organized by the international organization Laboratory of the Government
Chemist
£ Investors and pharmaceutical companies can establish their own Contract
Research Organizations (CRO) in Armenia, or invest in or collaborate with existing
CROs, research institutions or pharmaceutical producers with CRO capabilities
£ Competitive advantages in the manufacturing of generics, active pharmaceutical
ingredients (APIs), vaccines, and, with 2500 medicinal herbs growing in Armenia,
herbal medicine
£ Armenia has vast R&D resources and rich human capital of professionals in
Biochemistry, Molecular Genetics, and Microbiology
£ FMD K&L, a global contract research organization, has established the largest
biotechnology park of the region in Armenia. The company plans to grow to
employ 500 people in the next few years
7